Usefulness of short-term eltrombopag treatment as a supportive treatment in hepatocellular carcinoma patients with cirrhosis and severe thrombocytopenia: A report of two cases

Eltrombopag is an oral thrombopoietin (TPO) receptor agonist that increases platelet counts in patients with idiopathic thrombocytopenic purpura and in patients with liver cirrhosis. When cirrhotic patients with thrombocytopenia undergo elective invasive procedures, eltrombopag treatment reduces the...

Descripción completa

Detalles Bibliográficos
Autores principales: KAWAGUCHI, TAKUMI, NAKANO, MASAHITO, SATANI, MANABU, SUMIE, SHUJI, YAMADA, SHINGO, AMANO, KEISUKE, KUROMATSU, RYOKO, SATA, MICHIO
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2014
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4049767/
https://www.ncbi.nlm.nih.gov/pubmed/24932302
http://dx.doi.org/10.3892/ol.2014.1976

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4049767/
https://www.ncbi.nlm.nih.gov/pubmed/24932302
http://dx.doi.org/10.3892/ol.2014.1976

Ejemplares similares